← Eichor
Study identifier: NCT06134232 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

Condition: Metastatic Castration-Resistant Prostate Cancer (mCRPC)  ·  Sponsor: Dendreon

PhasePhase 2
Planned participants400
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

A multicenter, open-label, prospective study to investigate immune boost response changes in patients with metastatic castrate-resistant prostate cancer (mCRPC).

This description comes directly from the study's public registry record.

Talk to the study team

Margaret Warner-Lubin  ·  2064588358  ·  ProvONE@dendreon.com

Always discuss trial participation with your own doctor first.

Locations (31)

Arizona Urology SpecialistsTuscon, Arizona, United StatesRecruiting
City of Hope - National Medical CenterDuarte, California, United StatesRecruiting
Urology Associates of Central California Medical GroupFresno, California, United StatesRecruiting
Unio Health Partners - Genesis Research, LLCSan Diego, California, United StatesRecruiting
Colorado UrologyLakewood, Colorado, United StatesRecruiting
Advanced Urology InstituteDaytona Beach, Florida, United StatesRecruiting
Advanced Urology InstituteLargo, Florida, United StatesRecruiting
Advanced Urology InstituteOcala, Florida, United StatesRecruiting
Florida Urology PartnersRiverview, Florida, United StatesRecruiting
Associated Urological SpecialistsChicago Ridge, Illinois, United StatesActive Not Recruiting
UroPartnersGlenview, Illinois, United StatesRecruiting
Advanced Urology AssociatesNew Lenox, Illinois, United StatesRecruiting

+ 19 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06134232